Literature DB >> 221524

Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone.

N H Farkouh, M G Packer, A G Frantz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 221524     DOI： 10.1210/jcem-48-6-1026

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  11 in total

1.  Heterogeneity of serum prolactin in patients with menstrual disorder in conjunction with hyperthyroxinemia.

Authors:  H Tamai; O Mizuno; A Takaki; K Kiyohara; G Komaki; S Matsubayashi; K Kuma; L F Kumagai; S Nagataki
Journal:  J Endocrinol Invest       Date:  1991-09       Impact factor: 4.256

2.  Prevalence and reproductive manifestations of macroprolactinemia.

Authors:  Amanpreet Kaur Kalsi; Ashutosh Halder; Manish Jain; P K Chaturvedi; J B Sharma
Journal:  Endocrine       Date:  2018-09-29       Impact factor: 3.633

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

4.  Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.

Authors:  M F Celani; G Giambuzzi; M Simoni; V Montanini
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

Review 5.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

6.  Pseudohypergonadotropinemia and pseudohyperprolactinemia induced by heterophilic antibodies?

Authors:  J S Dericks-Tan; A Jost; U Schwedes; H D Taubert
Journal:  Klin Wochenschr       Date:  1984-03-15

7.  50 kD prolactin binding protein in schizophrenics on neuroleptic medication.

Authors:  A M Walker; C A Peabody; T W Ho; M D Warner
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

8.  Variations in the molecular forms of prolactin during the menstrual cycle, pregnancy and lactation.

Authors:  M E Fonseca; R Ochoa; C Morán; A Zárate
Journal:  J Endocrinol Invest       Date:  1991-12       Impact factor: 4.256

9.  Unusual heterogeneity of circulating prolactin in an acromegalic.

Authors:  A D Rogol; R C Eastman; T Manolio; S W Rosen
Journal:  J Endocrinol Invest       Date:  1981 Apr-Jun       Impact factor: 4.256

Review 10.  Hyperprolactinemia.

Authors:  Jaspreet Chahal; Janet Schlechte
Journal:  Pituitary       Date:  2008       Impact factor: 4.107
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.